Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli
- 337 Downloads
In recent years, the widespread use of antibiotics has caused many bacterial pathogens resistance to conventional antibiotics. Therefore, generation of new antibiotics to control and reduce the effects of these pathogens is urgently needed. Antimicrobial peptides and proteins are important members of the host defense system in eukaryotes. These peptides are potent, broad-spectrum antibiotics that demonstrate potential as novel and alternative therapeutic agents for the treatment of drug-resistant infections. Accordingly, we evaluated two hybrid peptides CM11 (WKLFKKILKVL-NH2) and CM15 (KWKLFKKIGAVLKVL-NH2) on five important pathogenic bacteria. These peptides are short cecropin–melittin hybrid peptides obtained through a sequence combination approach, which are highly effective to inhibit the growth of important pathogenic bacteria. The activity of these two cationic peptides (CM11 and CM15) in different concentrations (2–64 mg/L) was investigated against standard and clinical isolates of important hospital infection bacteria by measuring MIC, MBC, and bactericidal assay. These peptides demonstrated the same ranges of inhibitory values: The organisms in early 24 h were more susceptible to polycationic peptides (MIC: 8 mg/L and MBC 32 mg/L), but after 48 h the MIC and MBC remained constant for the CM11 peptide. Bactericidal assay showed that all bacteria strains did not have any growth in agar plates after 40 min. The result showed that these two peptides are more effective than other peptides.
KeywordsHybrid peptide Cecropin Melittin Antimicrobial peptides
We thank from clinical microbiology laboratory of Baqiyatallah, Khatam al anbia and Shahid motahari hospitals for preparing bacterial strains.
- 20.Dempsey CE (1990) The actions of melittin on membranes. Biochim Biophys Acta 1031(2):143–161Google Scholar
- 26.Saugar JM, Rodriguez-Hernandez MJ, de la Torre BG, Pachon-Ibanez ME, Fernandez-Reyes M, Andreu D, Pachon J, Rivas L (2006) Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of A. baumannii: molecular basis for the differential mechanisms of action. Antimicrob Agents Chemother 50(4):1251–1256CrossRefGoogle Scholar
- 29.Giacometti A, Cirioni O, Kamysz W, D’Amato G, Silvestri C, Simona Del Prete M, Lukasiak J, Scalise G (2004) In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1–7)M(2–9)NH(2) on methicillin-resistant nosocomial isolates of S. aureus and interactions with clinically used antibiotics. Diagn Microbiol Infect Dis 49(3):197–200CrossRefGoogle Scholar
- 30.Jarvis WR (2003) Epidemiology and control of P. aeruginosa infections in the intensive care unit. In: Hauser AR, Rello J (eds) Severe infections caused by P. aeruginosa. Kluwer Academic, BostonGoogle Scholar
- 35.Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE MJR, Talan DA, Chambers HF (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant S. aureus infections in adults and children: executive summary. Clin Infect Dis 52(3):285–292CrossRefGoogle Scholar
- 39.National Committee for Clinical Laboratory Standards (2010) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard M7-A6. Villanova, PAGoogle Scholar
- 42.Piers KL, Brown MH, Hancock RE (1994) Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother 38(10):2311–2316Google Scholar
- 43.Sawyer JG, Martin NL, Hancock RE (1988) Interaction of macrophage cationic proteins with the outer membrane of P. aeruginosa. Infect Immun 56(3):693–698Google Scholar
- 44.Rodriguez-Hernandez MJ, Saugar J, Docobo-Perez F, de la Torre BG, Pachon-Ibanez ME, Garcia-Curiel A, Fernandez-Cuenca F, Andreu D, Rivas L, Pachon J (2006) Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of A. baumannii. J Antimicrob Chemother 58(1):95–100CrossRefGoogle Scholar